Table 1.

Exploratory Factor Analysis Loadings for Medication-Assisted Treatment (MAT) Importance and Confidence Items

	Importance items		Confidence items
	Care process	Patient interaction	Care process	Patient interaction
Implementing Buprenorphine opioid treatment, managing its long-term maintenance on medications	0.87		0.91
Matching patients to appropriate MAT medications (methadone, buprenorphine, naltrexone)	0.86		0.89
Defining goals of MAT with patients	0.83		0.88
Implementing Naltrexone opioid treatment, managing its long-term maintenance on medications	0.80		0.88
Discussing MAT medication effects and side effects with patients	0.78		0.84
Detailing MAT approaches (methadone, buprenorphine, naltrexone) and medication protocols for opioid use disorders with patients	0.78		0.84
Treating specialized populations with MAT	0.73		0.84
Discussing the effectiveness of MAT for opioid use disorders with patients	0.72		0.79
Familiarizing patients with laws, regulations and oversights involved with agonist-based and partial agonist treatments	0.69		0.78
Using reflective listening		0.99		0.99
Using open body language		0.86		0.89
Demonstrating assertive compassion		0.77		0.78

Notes: Extraction method was maximum likelihood; rotation method was Promax with Kaiser normalization. Loadings <0.20 are not shown. All loadings are from the pattern matrix.